Please ensure Javascript is enabled for purposes of website accessibility

What Happened in the Stock Market Today

By Jim Crumly – Apr 16, 2019 at 4:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Johnson & Johnson's earnings results were better than expected, and UnitedHealth Group reported strong growth but stirred investor angst.

Stocks opened higher but drifted lower during the session as investors digested early first-quarter earnings reports. The Dow Jones Industrial Average (^DJI -1.40%) and the S&P 500 (^GSPC -1.79%) closed with small gains, and advancing issues outnumbered declining ones.

Today's stock market

Index Percentage Change Point Change
Dow 0.26% 67.89
S&P 500 0.05% 1.48

Data source: Yahoo! Finance.

Johnson & Johnson (JNJ -0.06%) and UnitedHealth Group (UNH -0.21%) both reported strong quarterly results, but comments by UnitedHeath's CEO contributed to a sell-off of related stocks.

Front of the New York Stock Exchange.

Image source: Getty Images.

Drug sales help Johnson & Johnson hold its own

Johnson & Johnson beat expectations for first-quarter results and raised full-year guidance, and shares rose 1.1%. Revenue was flat at $20 billion but exceeded the analyst consensus of $19.6 billion. Earnings per share declined 13.1%, but after adjusting for special items including litigation expense, EPS grew 1.9% to $2.10. Wall Street was expecting EPS of $2.04 on that basis.

Johnson & Johnson reported that sales growth on an operational basis, which excludes currency effects, acquisitions, and divestitures, was 5.5%. That increase was mostly due to a strong performance by the company's pharmaceutical business, which had operational growth of 7.9%. Gains from anti-inflammatory medicine Stelara and cancer drugs Imbruvica and Darzalex overcame the decline by Remicade, the company's top revenue-generating drug, which is under competitive pressure from biosimilars. Consumer sales increased 0.7% operationally and medical devices grew 4.3%.

Johnson & Johnson raised guidance for operational sales growth in 2019 from 2%-3% to 2.5%-3.5%, saying on the conference call that the effect of biosimilar competition will be toward the low end of its earlier estimate and that sales of its core products remain strong.

UnitedHealth Group reports strong growth

Health insurance giant UnitedHealth Group reported strong revenue and profit growth in the first quarter, but shares fell 4% after opening higher on the news. Revenue grew 9.3% to $60.3 billion and adjusted earnings per share increased 22.7% to $3.73. Analysts were expecting the company to earn $3.59 per share on revenue of $59.7 billion.

UnitedHealth's Optum division, which provides health services including pharmacy benefit management, had 11.7% revenue growth and a 13.6% increase in operating profit. The company's UnitedHealthcare unit, which provides health insurance coverage, grew revenue by 7.6% and operating profit by 23.1%. The overall company expanded net margin to 5.7% from 5.1% in the period a year earlier. UnitedHealth also raised its full-year EPS guidance 5% at the midpoint to a range of $14.50 to $14.75.

Despite stellar results, CEO David Wichmann may have triggered investor anxiety with prepared remarks attacking "Medicare for All" proposals, saying that some approaches could destabilize the nation's health system. Analysts on the conference call were also concerned about the impact of potential changes to the rebate system.

Jim Crumly owns shares of Johnson & Johnson. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
$178.78 (-0.06%) $0.10
UnitedHealth Group Stock Quote
UnitedHealth Group
$535.04 (-0.21%) $-1.12
Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$33,947.10 (-1.40%) $-482.78
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
$3,998.84 (-1.79%) $-72.86

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.